SPRC SciSparc Ltd.

Nasdaq scisparc.com


$ 3.29 $ 0.00 (0 %)    

Friday, 31-Oct-2025 19:22:02 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 3.25
$ 3.27
$ 3.23 x 119
$ 3.85 x 100
$ 3.20 - $ 3.34
$ 1.75 - $ 37.59
21,774
na
109,368
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

N2OFF, Inc. (NASDAQ:NITO) ("N2OFF" and the "Company"), a cleantech company investing in solar energy assets bas...

Core News & Articles

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

Core News & Articles

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

 scisparc-expands-biotech-ambitions-buys-stake-in-miza-iii-ventures

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...

Core News & Articles

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

 scisparc-and-automax-call-off-merger

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

 scisparc-terminates-automax-merger-secures-625m-repayment-plan-with-structured-interest-terms

SciSparc Ltd. (NASDAQ:SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company fo...

Core News & Articles

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's...

Core News & Articles

TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd.

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION